AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 50 filers reported holding AURA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -16.8% | 22,650 | +14.7% | 0.02% | -21.7% |
| Q2 2023 | $244 | +10.9% | 19,750 | -16.5% | 0.02% | +27.8% |
| Q1 2023 | $220 | -10.9% | 23,666 | +0.7% | 0.02% | -14.3% |
| Q4 2022 | $247 | -99.9% | 23,500 | +119.6% | 0.02% | +90.9% |
| Q3 2022 | $194,000 | -5.8% | 10,700 | -26.4% | 0.01% | -15.4% |
| Q2 2022 | $206,000 | – | 14,541 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $66,878,000 | 18.12% |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $4,620,000 | 1.42% |
| Matrix Capital Management Company, LP | 4,112,870 | $90,483,000 | 1.09% |
| Rock Springs Capital Management LP | 1,008,114 | $22,179,000 | 0.56% |
| Nantahala Capital Management | 301,990 | $6,644,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,297,019 | $28,534,000 | 0.05% |
| Citadel Advisors | 2,316,653 | $48,263,000 | 0.01% |
| Allianz Asset Management GmbH | 55,145 | $1,213,000 | 0.00% |
| BARCLAYS PLC | 59,697 | $1,314,000 | 0.00% |
| FMR LLC | 494,109 | $10,870,000 | 0.00% |